The concomitant usage of buprenorphine and CYP3A4 inducers can decrease the plasma focus of buprenorphine [see CLINICAL PHARMACOLOGY], potentially causing lessened efficacy or onset of a withdrawal syndrome in individuals who have created physical dependence to buprenorphine.All trials used buprenorphine in conjunction with psychosocial counseling … Read More